Saturday, December 12, 2015 2:13:51 AM
Sine people love buying into companies that have lots of warrants because they know the MM will run up the price upon exersise.
I think the price went up here on expectation of milestones being hit. Of course this series A warrants were sold into the market. Doubt Dart sold any if his though. Not sure about the math but I don't believe this is anywhere where dilution would hurt the sp in the long run.
They're playing for a piece if the pie in a 6B market place. That's just the HER2NEU vaccine. If the Fra can become SOC one day that's another 2B. Not to mention colerectal cancer, NSCLC, and Small Pox.
Then they have the collaboration with a PD1. This company will be bought out IMO long before any vaccine ever hits the market.
$6-$10 is an achievable TP even with every warrant exersised.
I loaded up on some dramamine for the bumpy ride and put many already on ignore for the BS. If there was only a pill to treat that. Now that would be a 100B dollar market place.
Best of luck!
And have a pleasant weekend everyone!
I think the price went up here on expectation of milestones being hit. Of course this series A warrants were sold into the market. Doubt Dart sold any if his though. Not sure about the math but I don't believe this is anywhere where dilution would hurt the sp in the long run.
They're playing for a piece if the pie in a 6B market place. That's just the HER2NEU vaccine. If the Fra can become SOC one day that's another 2B. Not to mention colerectal cancer, NSCLC, and Small Pox.
Then they have the collaboration with a PD1. This company will be bought out IMO long before any vaccine ever hits the market.
$6-$10 is an achievable TP even with every warrant exersised.
I loaded up on some dramamine for the bumpy ride and put many already on ignore for the BS. If there was only a pill to treat that. Now that would be a 100B dollar market place.
Best of luck!
And have a pleasant weekend everyone!
Recent MRKR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:30:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/20/2026 08:08:49 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/20/2026 08:07:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/20/2026 08:05:49 PM
- Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results • GlobeNewswire Inc. • 03/18/2026 09:31:30 PM
- Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/18/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 09:06:45 PM
- Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology • GlobeNewswire Inc. • 01/26/2026 12:00:00 PM
- Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer • GlobeNewswire Inc. • 01/05/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:10:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:01:15 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/17/2025 09:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 12:20:47 PM
- Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/14/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:29:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 12:36:59 PM
- Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors • GlobeNewswire Inc. • 11/05/2025 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 10:09:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 10:03:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 09:54:39 PM
- Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting • GlobeNewswire Inc. • 11/03/2025 02:15:00 PM
- Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program • GlobeNewswire Inc. • 10/06/2025 11:30:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 11:30:37 AM
